Bradykinin protects against oxidative stress-induced endothelial cell senescence.

Hypertension

Volumn 53, Issue 2, 2009, Pages 417-422

  Oeseburg, Hisko ^a   Iusuf, Dilek ^a   van der Harst, Pim ^a   van Gilst, Wiek H ^a   Henning, Robert H ^a   Roks, Anton J M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ; BRADYKININ B2 RECEPTOR; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DRUG DERIVATIVE; ICATIBANT; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; VASODILATOR AGENT;

ANIMAL; ARTICLE; CATTLE; CELL AGING; CELL CULTURE; CELL MOTION; CYTOLOGY; DNA DAMAGE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; OXIDATIVE STRESS; VASCULAR ENDOTHELIUM;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BRADYKININ; CATTLE; CELL AGING; CELL MOVEMENT; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; NITRIC OXIDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RECEPTOR, BRADYKININ B2; VASODILATOR AGENTS;

EID: 59849109480     PISSN: None     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.123729     Document Type: Article

References (0)